Sartorius Stedim Biotech has unveiled a new single-use vessel for its ambr 250 modular benchtop automated mini bioreactor system that has been specifically designed for therapeutic cell lines.
According to the Pharmaceutical Research and Manufacturers of America (PhRMA), some 362 cell and gene therapies are now in clinical development in the United States, up from 289 in 2018. 1 Although ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback